Birinyi Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-6,350
| Closed | -$529K | – | 87 |
|
|
2016
Q2 | $529K | Sell |
6,350
-1,450
| -19% | -$121K | 0.23% | 60 |
|
|
2016
Q1 | $717K | Sell |
7,800
-1,150
| -13% | -$106K | 0.32% | 53 |
|
|
2015
Q4 | $906K | Sell |
8,950
-3,100
| -26% | -$314K | 0.59% | 44 |
|
|
2015
Q3 | $1.18M | Buy |
12,050
+5,550
| +85% | +$545K | 0.51% | 43 |
|
|
2015
Q2 | $761K | Sell |
6,500
-3,350
| -34% | -$392K | 0.52% | 45 |
|
|
2015
Q1 | $967K | Sell |
9,850
-1,100
| -10% | -$108K | 0.64% | 39 |
|
|
2014
Q4 | $1.03M | Buy |
10,950
+2,600
| +31% | +$245K | 0.46% | 41 |
|
|
2014
Q3 | $889K | Buy |
8,350
+4,750
| +132% | +$506K | 0.4% | 42 |
|
|
2014
Q2 | $298K | Buy |
+3,600
| New | +$298K | 0.14% | 76 |
|
|
2013
Q4 | – | Sell |
-1,600
| Closed | -$101K | – | 82 |
|
|
2013
Q3 | $101K | Buy |
+1,600
| New | +$101K | 0.06% | 95 |
|